Status:
COMPLETED
Treating Sleep Apnea Induced Hypoxemia With Oxygen in Acute Stroke Patients
Lead Sponsor:
Mayo Clinic
Conditions:
Stroke, Acute
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
We want to determine if treating acute ischemic stroke patients who have evidence of hypoxemia due to sleep apnea with low flow O2 during sleep might help improve clinical and functional outcomes.
Detailed Description
Acute stroke patients will be tested for nocturnal hypoxemia using overnight oximetry. Those with evidence of hypoxemia will be randomized into two groups. One group will receive standard medical care...
Eligibility Criteria
Inclusion
- Patients presenting to Mayo Clinic Hospital with acute ischemic stroke
Exclusion
Key Trial Info
Start Date :
April 3 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2020
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT03300063
Start Date
April 3 2018
End Date
December 1 2020
Last Update
January 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905